AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma Pharmaceutical Investing
Bristol Myers Squibb Launches Disability Diversity in Clinical Trials Initiative to Improve Healthcare Outcomes for People with Disabilities Pharmaceutical Investing
Aptose to Report Second Quarter 2022 Financial Results and Hold Conference Call on Tuesday, August 2, 2022 Market News
Gilead Sciences Signs New Joint Procurement Agreement with the European Commission for Veklury® Pharmaceutical Investing
Clene Receives Positive EMA Opinion on Orphan Drug Designation for CNM-Au8® for the Treatment of ALS Life Science Investing
BELLUS Health Closes US$153 Million Public Offering of Common Shares in Canada and the United States Pharmaceutical Investing
Genmab Announces That AbbVie Will Submit Marketing Authorization Application to European Medicines Agency for Epcoritamab for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Pharmaceutical Investing
Ginkgo Bioworks Announces Latest Collaboration for Beauty and Personal Care Industry with Sumitomo Chemical Life Science Investing
AbbVie Submits Marketing Authorization Application to EMA for Atogepant for the Preventive Treatment of Migraine Pharmaceutical Investing
